Locus (ANRIL) was upregulated on mRNA level in AML people of different stages in comparison to normal controls and clients in finish remission (CR). Knockdown of ANRIL brought about enhanced senescence in HL-60 and MOLM-13 cells in vitro, also to increased survival charges upon transplantation in the latter in NOD/SCID https://abbak990pci9.wizzardsblog.com/profile